703 related articles for article (PubMed ID: 20659133)
1. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133
[TBL] [Abstract][Full Text] [Related]
2. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Feng YL; Wen FQ; Huang XY; Xiao J; Wang K; Wang T
Chin Med J (Engl); 2008 Sep; 121(18):1821-9. PubMed ID: 19080365
[TBL] [Abstract][Full Text] [Related]
4. Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice.
Gurujeyalakshmi G; Wang Y; Giri SN
J Pharmacol Exp Ther; 2000 Apr; 293(1):82-90. PubMed ID: 10734156
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of a bacterially expressed NIF-KGF fusion protein against bleomycin-induced acute lung injury in mice.
Li X; Li S; Zhang M; Li X; Zhang X; Zhang W; Li C
Acta Biochim Biophys Sin (Shanghai); 2010 Aug; 42(8):548-57. PubMed ID: 20705596
[TBL] [Abstract][Full Text] [Related]
6. Early granulocyte-macrophage colony-stimulating factor expression by alveolar inflammatory cells during bleomycin-induced rat lung fibrosis.
Andreutti D; Gabbiani G; Neuville P
Lab Invest; 1998 Dec; 78(12):1493-502. PubMed ID: 9881949
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of emodin on bleomycin-induced pulmonary fibrosis in mice.
Chen XH; Sun RS; Hu JM; Mo ZY; Yang ZF; Jin GY; Guan WD; Zhong NS
Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):146-53. PubMed ID: 18785980
[TBL] [Abstract][Full Text] [Related]
8. Feitai, a Chinese herbal medicine, reduces transforming growth factor-beta1 and monocyte chemoattractant protein-1 expression in bleomycin-induced lung fibrosis in mice.
Shen Y; Zhao HL; Du J; Li YT; Tan F; Huang CG; Pei G
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1071-7. PubMed ID: 16445573
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of pirfenidone on acute pulmonary injury and ensuing fibrosis in the hamster model of amiodarone-induced pulmonary toxicity.
Card JW; Racz WJ; Brien JF; Margolin SB; Massey TE
Toxicol Sci; 2003 Sep; 75(1):169-80. PubMed ID: 12832656
[TBL] [Abstract][Full Text] [Related]
10. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
11. (5R)-5-hydroxytriptolide (LLDT-8) protects against bleomycin-induced lung fibrosis in mice.
Ren YX; Zhou R; Tang W; Wang WH; Li YC; Yang YF; Zuo JP
Acta Pharmacol Sin; 2007 Apr; 28(4):518-25. PubMed ID: 17376291
[TBL] [Abstract][Full Text] [Related]
12. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S
Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734
[TBL] [Abstract][Full Text] [Related]
13. Administration of a specific inhibitor of neutrophil elastase attenuates pulmonary fibrosis after acute lung injury in mice.
Fujino N; Kubo H; Suzuki T; He M; Suzuki T; Yamada M; Takahashi T; Ota C; Yamaya M
Exp Lung Res; 2012 Feb; 38(1):28-36. PubMed ID: 22148910
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of pravastatin on lipopolysaccharide-induced acute lung injury during neutropenia recovery in mice.
Yeo CD; Rhee CK; Kim IK; Kang HH; Lee SH; Lee SY; Kwon SS; Kim YK; Kim KH; Kim JW
Exp Lung Res; 2013 Mar; 39(2):99-106. PubMed ID: 23368428
[TBL] [Abstract][Full Text] [Related]
15. [A preliminary study of CTGF in bleomycin-induced mouse pulmonary fibrosis].
Zhang L; Lu HP; Lai GX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 May; 21(3):290-2. PubMed ID: 15862142
[TBL] [Abstract][Full Text] [Related]
16. Involvement of leukotrienes in the pathogenesis of silica-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Exp Lung Res; 2010 Jun; 36(5):292-301. PubMed ID: 20497024
[TBL] [Abstract][Full Text] [Related]
17. Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice.
Izumo T; Kondo M; Nagai A
Life Sci; 2007 Apr; 80(20):1882-6. PubMed ID: 17397875
[TBL] [Abstract][Full Text] [Related]
18. STY39, a novel alpha-melanocyte-stimulating hormone analogue, attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice.
Xu PB; Mao YF; Meng HB; Tian YP; Deng XM
Shock; 2011 Mar; 35(3):308-14. PubMed ID: 20926985
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
Corbel M; Caulet-Maugendre S; Germain N; Molet S; Lagente V; Boichot E
J Pathol; 2001 Apr; 193(4):538-45. PubMed ID: 11276015
[TBL] [Abstract][Full Text] [Related]
20. Exacerbation of bleomycin-induced injury and fibrosis by pneumonectomy in the residual lung of mice.
Kakizaki T; Kohno M; Watanabe M; Tajima A; Izumi Y; Miyasho T; Tasaka S; Fukunaga K; Maruyama I; Ishizaka A; Kobayashi K
J Surg Res; 2009 Jun; 154(2):336-44. PubMed ID: 19118846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
